TAPISTRON INTERNATIONAL INC
10-Q, 1998-06-11
SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)
Previous: STANDISH AYER & WOOD INVESTMENT TRUST, 497, 1998-06-11
Next: MERRILL LYNCH INTERMEDIATE GOVERNMENT BOND FUND, N-30D, 1998-06-11



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C., 20549


                                    Form 10-Q


[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the quarterly period ended April 30, 1998

                                       OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

   For the transition period from ______________________ to ____________________

                         Commission file number 0-20309

                          TAPISTRON INTERNATIONAL, INC.
                          -----------------------------
             (Exact name of registrant as specified in its charter)

             Georgia                                 58-1684918
             -------                                 -----------
(State or other jurisdiction of                     (IRS Employer
 incorporation or organization                    Identification No.)

                              6203 Alabama Highway
                                  P.O. Box 1067
                                Ringgold, Georgia
                    (Address of principal executive offices)

                                   30736-1067
                                   (Zip Code)

                                 (706) 965-9300
              (Registrant's telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
 [X] Yes                                       [ ] No

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the most recent practicable date.

               Class                               Outstanding at June 10, 1998
   -----------------------------                   ----------------------------
   Common Stock $.0004 Par Value                            34,785,611


                                       1

<PAGE>

                         TAPISTRON INTERNATIONAL, INC.

                               TABLE OF CONTENTS
<TABLE>
<CAPTION>


                                                                                                PAGE
                                                                                                ----

<S>                                                                                              <C>   
PART I - FINANCIAL INFORMATION

   ITEM 1 - FINANCIAL STATEMENTS

     Condensed Consolidated Balance Sheets as of July 31, 1997 and April 30, 1998                 3

     Condensed Consolidated Statements of Operations for the Three Months Ended
        April 30, 1997 and 1998 and for the Nine Months Ended April 30, 1997 and 1998             4

     Condensed Consolidated Statements of Cash Flows for the Nine Months Ended
        April 30, 1997 and 1998                                                                   5

     Notes to Condensed Consolidated Financial Statements                                         6

   ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
   AND RESULTS OF OPERATIONS                                                                      10

PART II - OTHER INFORMATION

   ITEM 5 - OTHER INFORMATION                                                                     12

SIGNATURE                                                                                         12


</TABLE>


                                       2
<PAGE>
                          TAPISTRON INTERNATIONAL, INC.
                      CONDENSED CONSOLIDATED BALANCE SHEET

                                     ASSETS
<TABLE>
<CAPTION>

                                                                              Condensed from
                                                                              Audited Financial
                                                                                Statements           Unaudited
                                                                               July 31, 1997      April 30, 1998
                                                                              -----------------   --------------
<S>                                                                                  <C>                <C>     
   CURRENT ASSETS
        Cash and Cash equivalents                                                    $27,946            $484,757
        Receivables, net of allowances of $39,905 as of July 31, 1997
           and April 30, 1998                                                        720,740             374,219
        Notes Receivable                                                             350,000              66,667
        Inventory                                                                  1,231,002           1,670,301
        Prepayments                                                                  102,453             135,604
        Deferred income taxes                                                        100,000             100,000
                                                                                ------------         -----------         
             Total current assets                                                  2,532,141           2,831,548

   PROPERTY AND EQUIPMENT, NET                                                       564,324             521,226

   OTHER ASSETS
        Long-term receivables, net of allowances of $500,000 as of
           July 31, 1997 and April 30, 1998                                                -                   -
        Patents and patent license                                                   263,068             272,026
        Deferred income taxes                                                      1,900,000           1,900,000
        Other                                                                          8,247               6,673
                                                                                ------------         -----------         
             Total other assets                                                    2,171,315           2,178,699
                                                                                ------------         -----------         
             TOTAL                                                                $5,267,780          $5,531,474


                      LIABILITIES AND STOCKHOLDERS' EQUITY

   CURRENT LIABILITIES
        Short-term debt                                                                   $0                  $0
        Current Portion of long-term debt                                              4,315               1,693
        Accounts payable                                                             178,068             107,036
        Accrued expenses                                                             655,621             165,293
        Customer deposits                                                            936,026             100,000
                                                                                ------------         -----------         
             Total current liabilities                                             1,774,030             374,023

   LIABILITIES SUBJECT TO SETTLEMENT UNDER
      REORGANIZATION PROCEEDINGS                                                   2,520,557             350,000

   LONG-TERM DEBT                                                                        744                 744

   COMMITMENTS AND CONTINGENCIES                                                           0             447,918

   STOCKHOLDERS' EQUITY
        Preferred stock - $.001 par value - 2,000,000 shares
           authorized; no shares issued and outstanding                                    -                   -
        Common stock - $.0004 par value - 100,000,000 shares
           authorized; 10,581,813 outstanding as of July 31, 1997
           and 34,841,129 outstanding as of April 30, 1998                             4,233              13,936
        Additional paid-in capital                                                22,899,108          26,541,716
        Accumulated deficit                                                      (21,918,100)        (22,184,071)
        Treasury stock - 55,518 shares outstanding, at cost                          (12,792)            (12,792)
                                                                                ------------         -----------         
             Total stockholders' equity                                              972,449           4,358,789

             TOTAL                                                                $5,267,780          $5,531,474
</TABLE>

   The accompanying notes are an integral part of the financial statements.

                                       3

<PAGE>

                          TAPISTRON INTERNATIONAL, INC.
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                   (Unaudited)
<TABLE>
<CAPTION>

                                          Three months ended April 30,             Nine months ended April 30,
                                          ---------------------------              --------------------------
                                            1997               1998                1997                  1998
                                            ----               ----                ----                  ----
<S>                                           <C>               <C>               <C>                 <C>       
   SALES                                      $59,745           $954,692          $2,860,687          $3,701,614

   COST OF SALES                               37,256            576,976           2,032,465           2,247,143
                                          -----------        -----------        ------------         -----------         

             Gross profit                      22,489            377,716             828,221           1,454,470

   OPERATING EXPENSES
        General & Administrative expenses     612,121            594,452           1,273,209           1,745,432
                                          -----------        -----------        ------------         -----------         
                                              612,121            594,452           1,273,209           1,745,432
                                          -----------        -----------        ------------         -----------         

   OPERATING LOSS                            (589,632)          (216,736)           (444,987)           (290,961)
                                          -----------        -----------        ------------         -----------         

   OTHER INCOME (EXPENSE)
        Interest expense                            0             (2,175)            (54,837)            (10,657)
        Interest income                             0              3,018                   2              35,648
                                          -----------        -----------        ------------         -----------         
        Other income (expense)                      0                843             (54,836)             24,990
                                          -----------        -----------        ------------         -----------         

   NET LOSS                                  (589,632)          (215,892)           (499,823)           (265,971)


   EARNINGS PER SHARE

        Net loss                               (0.056)            (0.006)             (0.047)             (0.009)

        Weighted average number of
        shares outstanding                 10,526,295         34,785,611          10,526,295          28,906,466
</TABLE>

   The accompanying notes are an integral part of the financial statements.

                                       4
<PAGE>
                          TAPISTRON INTERNATIONAL, INC.
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                          Nine months ended April 30,
                                                                                          --------------------------
                                                                                           1997                1998
                                                                                           ----                ----
<S>                                                                                   <C>                   <C>  
   CASH FLOWS FROM OPERATING ACTIVITIES:
        Net loss                                                                        ($499,823)          ($265,971)
        Adjustments to reconcile net loss to net cash used by operating activities:
             Depreciation and amortization                                                130,706             143,490
             Changes in operating assets and liabilities:
                  (Increase) decrease in receivables                                      138,584             629,854
                  (Increase) decrease in prepayments                                       (9,766)            (33,151)
                  (Increase) decrease in inventory                                        914,012            (504,923)
                  Increase (Decrease) in customer deposits                                      0            (836,026)
                  Increase (Decrease) in accounts payable and accrued expenses            114,619            (186,360)
                  Increase (Decrease) in accounts payable and accrued expenses,
                      which are subject to settlement under a plan of reorganization            0            (945,328)
                                                                                      -----------         -----------              
                       Net cash provided by (used by) operating activities                788,332          (1,998,414)

   CASH FLOWS FROM INVESTING ACTIVITIES:
        Payments for other assets                                                          (5,000)            (23,939)
        Capital expenditures                                                              (17,440)            (18,214)
                                                                                      -----------         -----------              
                       Net cash (used by) investing activities                            (22,440)            (42,153)

   CASH FLOWS FROM FINANCING ACTIVITIES:
        Proceeds from issuance of debt                                                    599,970             400,000
        Proceeds from issuance of common stock                                                  0           2,500,000
        Principal payments of debt                                                     (1,007,167)           (402,622)
                                                                                      -----------         -----------              
                       Net cash provided by (used by) financing activities               (407,197)          2,497,378

   NET INCREASE (DECREASE) IN CASH EQUIVALENTS:                                           358,694             456,811
        Cash and cash equivalents - beginning of period                                    17,149              27,946
                                                                                      -----------         -----------              
        Cash and cash equivalents - end of period                                        $375,843            $484,757
                                                                                      ===========         ===========

   SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
        Cash paid for interest                                                            $19,569             $19,772
                                                                                      ===========         ===========
   SUPPLEMENTAL DISCLOSURES OF NONCASH INVESTING AND
        FINANCING ACTIVITIES:
        Transfers from fixed assets to inventory                                         $163,270                  $0
        Issuance of stock in lieu of professional fees                                         $0            $375,000
        Issuance of stock for reorganization debt                                              $0          $1,225,230
                                                                                      ===========         ===========
</TABLE>

   The accompanying notes are an integral part of the financial statements.

                                       5
<PAGE>

                          TAPISTRON INTERNATIONAL, INC.
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                                 April 30, 1998

                                   (Unaudited)


   NOTE 1 - BASIS OF PRESENTATION
   ------------------------------

   In the opinion of the management of Tapistron International, Inc.
   ("Tapistron") and Fabrication Center, Inc. ("FCI"), a wholly-owned subsidiary
   of Tapistron, the accompanying unaudited condensed consolidated financial
   statements contain all adjustments (consisting of only normal recurring
   adjustments, except as noted elsewhere in the notes to the condensed
   consolidated financial statements) necessary to present fairly its financial
   position as of April 30, 1998 and the results of its operations for the three
   and nine months ended April 30, 1997 and 1998, and cash flows for the nine
   months ended April 30, 1997 and 1998. These statements are condensed and
   therefore do not include all of the information and footnotes required by
   generally accepted accounting principles for complete financial statements.
   The statements should be read in conjunction with the consolidated financial
   statements and footnotes included in the Company's Annual Report on Form 10-K
   for the year ended July 31, 1997. The results of operations for the three and
   nine months ended April 30, 1998 are not necessarily indicative of the
   results to be expected for the full year.

   NOTE 2 - EARNINGS PER SHARE
   ---------------------------

   Earnings per common share is computed based on the weighted average number of
   common shares outstanding during each period presented and, when dilutive,
   common equivalent shares (stock options and warrants) outstanding during each
   of the periods.

   NOTE 3 - INVENTORY
   ------------------
<TABLE>
<CAPTION>
   Inventory at April 30, 1998 consists of the following:
<S>                                                                                 <C>     
        Raw Material                                                                $531,978
        Work in Process                                                            1,138,323
                                                                                ------------
                                                                                  $1,670,301
   NOTE 4 - FRESH START ACCOUNTING
   -------------------------------

   The Company does not meet the requirements for fresh start reporting based on
   the test found in paragraph 36 of SOP 90-7. As shown in the computations
   below, the holders of the existing voting shares immediately before
   confirmation received 50.08% of the voting shares of the emerging entity.

   Existing voting shares immediately before confirmation                         10,581,813

   Voting shares issued per plan of reorganization to shareholders owning
   existing voting shares immediately before confirmation                          6,837,295
                                                                                ------------
   Voting shares in the emerging entity held by holders of existing voting
   shares immediately before confirmation                                         17,419,108

   Total existing voting shares of the emerging entity                            34,785,611

   The holders of existing voting shares immediately before confirmation receive
   50.08% of the voting shares of the emerging entity.
</TABLE>
                                       6
<PAGE>
   NOTE 5 - LIABILITIES SUBJECT TO SETTLEMENT UNDER REORGANIZATION PROCEEDINGS
   ---------------------------------------------------------------------------

   The Company filed a Voluntary Petition for Chapter 11 Bankruptcy on June 21,
   1996. The original Plan of Reorganization of Tapistron International, Inc.
   was filed with the Court on November 21, 1996 (the "Plan"). An Amended and
   Restated Plan of Reorganization of Tapistron International, Inc. was filed
   with the Bankruptcy Court on March 14, 1997 (the "Amended Plan") and
   confirmed on August 18, 1997. After confirmation, the Company proceeded with
   an issuance of common stock at the rate of $0.15 per share for a total of
   16,666,666 shares.

   Under the Amended Plan of Reorganization, all creditors will be paid in full
   (unless the creditor elected to accept a discounted amount or the creditor
   and the Company agreed to different terms), with interest from stock and cash
   payments.

   In accordance with the Amended Plan, the treatment for each class of
   creditors is as follows:

   Class 1: In accordance with the Company's Amended Plan, the allowed Class 1
   Administrative Claims have been paid in full.

   Class 2:  The allowed Class 2 Claim of Metrahealth, Administrator for the
   Travelers, Employee Benefits Plan has been paid in full. (A)

   Class 3:  There were no Class 3 Claims.

   Class 4: The allowed Administrative Claim of Avonwood Capital Corporation as
   Company's investment banker for post-petition payments due for professional
   services to the Company is being satisfied in accordance with the terms of
   its employment as approved by the Court on November 12, 1996 and subsequently
   modified by the parties on August 11, 1997 over twenty (20) months by monthly
   retainer payments of $10,000 per month for nineteen (19) months and a final
   payment of $2,000 on the twentieth month, and issuance of 1,500,000 shares of
   the common stock of the Company, issued on November 12, 1997, pursuant to
   Section 5.5 of the Amended Plan and Section 1145 of the Bankruptcy Code.

   Class 5: The allowed Secured Claim of the holders of the Demoss Loan
   Documents, the Culbreath Loan Documents and the Parker Loan Documents, which
   were secured by liens upon the Company's personal property were paid from the
   liquidation of their collateral pre-confirmation. (B)

   Class 6: The allowed claim of the holders of the Landav Loan Documents were
   satisfied in exchange for the issuance and delivery of 4,092,629 shares of
   common stock on November 24, 1997. (C)

   Class 7: As provided for in the Amended Plan, each unsecured creditor shall
   receive its pro rata share (based on the amount of its allowed claim compared
   to the total of unsecured claims) of (i) cash in the amount of $500,000 plus
   (ii) its pro rata share of a second aggregate payment of $500,000 together
   with interest, payable at $50,000 per new machine sale by the Company. The
   balance of the unsecured claims, shall be paid as follows. Each unsecured
   creditor could elect one of two options with respect to the payment of the
   balance of its claim. Option 1: the sum of 15% of the balance of its claim.
   Option 2: the creditors pro rata share of 1,000,021 shares of common stock
   issued by the Company. At any time on or prior to September 30, 2000 (the
   "Final Settlement Date"), each unsecured creditor shall, at the sole and
   exclusive option of the Company, receive an additional cash payment or
   additonal shares of common stock based on the average of the closing prices
   of the Company's common stock for the period that is not less than five (5)
   nor more than thirty-five (35) trading days prior to the Final Settlement
   Date such that the total amount received by the unsecured creditors pursuant
   to this Option 2, either in additional stock or cash, equals its pro rata
   share of the difference between the total amount of unsecured claims less all
   principal amounts to be paid pursuant to the first $500,000 and the second
   aggregate amount of $500,000. If between the August 29, 1997 (the "Effective
   Date") and the September 30, 2000 the average of the closing prices of the
   Company's common stock for any five (5) consecutive trading day period
   multiplied by 1,000,021 

                                       7
<PAGE>

   exceeds the balance of unsecured claims multiplied by factor for time value
   or if any unsecured creditor shall sell, pledge, or trade the stock, directly
   or indirectly, issued to it, then such creditors shall no longer be entitled
   to any further distribution on the Final Settlement Date.
   On September 12, 1997, each holder of an allowed Class 7 unsecured claim
   received their prorata share of the first $500,000 payment in cash and on
   November 28, 1997, the creditors that elected Option 1 received their 15%
   payment. In addition, the creditors that elected Option 2 received their
   prorata share of the 1,000,000 shares of common stock issued on November 25,
   1997. As of April 30, 1998, the Company had made $150,000 toward the second
   $500,000 cash payment payable at $50,000 per new machine sale. (D,E,F)

   Class 8: Each holder of an allowed Class 8 convenience claim, or those
   claimants electing Class 8 treatment received their payment in cash equal to
   the lesser of $1,200 or the allowed amount of such allowed convenience claim
   on September 19, 1997. (G)

   Class 9: The holders of the Class 9 claims had their equity interest in the
   Company diluted by the common stock of the Company issued to implement the
   Amended Plan and any existing preemptive rights to acquire, and other rights
   to limit issuance of, the Company's common stock have been cancelled.

   Class 10: The holders of the outstanding Redeemable Warrants to acquire
   common stock of the Company had their rights to acquire equity interests
   modified.

   Class 11: The holders of outstanding options to acquire common stock of the
   Company have had their stock options cancelled and rejected and shall hold no
   claim.

   Class 12: The holders of outstanding, non-redeemable, non-public warrants to
   acquire common stock of the Company retain the rights as set forth under the
   various representative warrant agreements or other agreements with respect to
   non-public, non-redeemable warrants.

   Class 13: The claim of Associates Commericial Corporation, Inc. shall be as
   set forth in the "Consent Order Allowing Use of Cash Collateral And Providing
   for Adequate Protection" entered by the Court on November 12, 1996.

   In addition, the Company was authorized from the Court to incur secured debt
   on January 14, 1997 from Ameristar Capital Corporation. For services
   rendered, Ameristar Capital Corporation received a security interest and lien
   on one CYP Machine No. 414 to secure repayment of the loan and to pay a
   placement fee of $25,000 to Avonwood Capital Corporation from the proceeds of
   the loan and to issue 1,000,000 shares of the Company's common stock in
   accordance with its plan of reorganization. Shares of common stock were
   issued as of November 25, 1997.

   Liabilities Subject to Settlement under Reorganization Proceedings
   ------------------------------------------------------------------
<TABLE>
<CAPTION>
<S>                                                                               <C>       
   July 31, 1997 Pre-confirmation                                                 $2,520,557
   (A) Class 2 Metrahealth Claim                                                     ($7,911)
   (B) Class 5 Culbreath Loan Documents                                             ($50,000)
   (C) Class 6 Landav Loan Documents exchanged for stock                           ($613,894)
   (D) Class 7 First $500,000 payment                                              ($500,000)
   (E) Class 7 Option 1 payment                                                     ($89,300)
   (F) Class 7 Option 2 shares issued for debt                                     ($611,336)
   (G) Class 8 Convenience Claims                                                   ($49,253)
   Adjustment from Pre-confirmation to Confirmation                                 ($98,863)
   Payments on the second $500,000 to Class 7 unsecured creditors                  ($150,000)
                                                                              --------------
   Second $500,000 to be payable $50,000 per new machine sale                       $350,000

   Contingency for stock that will cover Class 7 debt                               $447,918
                                                                              --------------
   Total liabilities subject to settlement under reorganization proceedings         $797,918
                                                                              ==============
</TABLE>

                                       8
<PAGE>
   NOTE 6 - COMMITTMENTS AND CONTINGENCIES
   ---------------------------------------

   Under the Amended Plan, the Class 7 unsecured creditors are to receive their
   prorata share of the first $500,000 cash payment and their prorata share of a
   second $500,000 cash payment, payable at $50,000 per new machine sale. With
   regard to the balance of their claim, each unsecured creditor could elect
   either (1) 15% of the balance of its claim or (2) the creditors prorata share
   of 1,000,021 shares of common stock issued by the Company. If between the
   August 29, 1997 and September 30, 2000 the average of the closing prices of
   the Company's common stock for any five (5) consecutive trading day period
   multiplied by 1,000,000 exceeds the balance of unsecured claims multiplied by
   factor for time value or if any unsecured creditor shall sell, pledge, or
   trade the stock, directly or indirectly, issued to it, then such creditors
   shall no longer be entitled to any further distribution.
<TABLE>
<CAPTION>
<S>                                                                                  <C>    
   April 30, 1998 closing market price                                               $0.2000
   Shares issued to Class 7 (no fractional shares were issued)                     1,000,021
                                                                              --------------
   Total Market Value of Class 7 Stock                                              $200,004

   Balance of Class 7 unsecured claims                                              $611,336
   Time value factor @ 8.75%                                                      1.05984676
                                                                              --------------
   Total Liability of Class 7 Claims                                                $647,922

   Total contingency for stock that will cover Class 7 debt                         $447,918
                                                                              ==============
</TABLE>

                                       9
<PAGE>

   Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
   RESULTS OF OPERATIONS

        The following discussion and analysis provides information which
   management believes is relevant to an assessment and understanding of the
   Company's consolidated results of operations and financial condition. The
   discussion should be read in conjunction with the consolidated financial
   statements and notes thereto.

   Results of Operations

   Sales
   -----

       Sales, by quarter, for the nine months ended April 30, 1998, and 1997
   are summarized as follows:

                                         Fiscal 1998        Fiscal 1997
                                         -----------        -----------
   Quarter ended October 31                $1,249,830         $1,561,874
   Quarter ended January 31                 1,497,092          1,239,068
   Quarter ended April 30                     954,692             59,745
                                       --------------     --------------        
   Nine months ended April 30              $3,701,614         $2,860,687
                                       ==============     ==============

        Sales of $954,692 for the third quarter of Fiscal 1998 exceeded the
   sales of $59,745 for the third quarter of Fiscal 1997. Sales for the first
   nine months of Fiscal 1998 amounted to $3,701,614, reflecting an increase of
   29% over sales of $2,860,687 for the first nine months of Fiscal 1997.

        Combined sales in the first and second quarter of Fiscal 1998 were
   $2,746,922 compared to $2,800,942 for the first and second quarter of Fiscal
   1997, a decrease of 2%.

        In the third quarter of Fiscal 1998, there was an increase of $894,947
   in sales, as compared to the third quarter of Fiscal 1997. This increase was
   due to an increase in sales volume. During the third quarter of Fiscal 1997,
   the Company did not have any CYP machine sales.

        The Company's sales for the nine months of Fiscal 1998 exceeded the
   sales for the nine months of Fiscal 1997 by 29%. The increase in sales is a
   result of machines being sold at lower margins in the nine months of Fiscal
   1997 due to the need to generate cash to support operations and technical
   support of the CYP machines during the reorganization proceedings.

        The Company's sales for the nine months ended April 30, 1998
   ($3,701,614) have exceeded the total sales for the fiscal year ended July 31,
   1997 ($3,626,092). Furthermore, the Company currently has sales orders for
   CYP machines totaling $1,850,000, which it expects to complete and ship in
   the fourth quarter of Fiscal 1998.

   Cost of Sales
   -------------

        Cost of sales as a percentage of sales, by quarter, for the nine months
   ended April 30, 1998, and 1997 are summarized as follows:

                                         Fiscal 1998        Fiscal 1997
                                         -----------        -----------

   Quarter ended October 31                  67%                71%
   Quarter ended January 31                  56%                72%
   Quarter ended April 30                    60%                62%
                                       --------------     --------------
   Nine months ended April 30                61%                71%
                                       ==============     ==============

        Cost of sales as a percentage of sales decreased from 71% for the nine
   months ended April 30, 1997 to 61% for the nine months ended April 30, 1998.
   During the nine months ended April 30, 1997, the Company 


                                       10
<PAGE>

   sold machines at lower margins in order to generate cash and support
   operations while under Chapter 11 protection. In addition, the Company is
   beginning to realize benefits from cost control measures implemented such as
   cross-training of employees. The Company's purchasing power has increased due
   to its stronger financial condition.

   Operating Expenses
   ------------------

        Operating expenses as a percentage of sales, by quarter, for the nine
   months ended April 30, 1998, and 1997 are summarized as follows:

                                         Fiscal 1998        Fiscal 1997
                                         -----------        -----------
   Quarter ended October 31                  52%                22%
   Quarter ended January 31                  33%                26%
   Quarter ended April 30                    62%               1025%
                                       --------------     --------------
   Nine months ended April 30                47%                45%
                                       ==============     ==============

        Operating expenses as a percentage of sales for the nine months ended
   April 30, 1998 was 47% compared to 45% for the nine months ended April 30,
   1997. Operating expenses as a percentage of sales fluctuates between quarters
   due to the timing and shipment of orders for the CYP machines. The increase
   in percentage is due to increased personnel costs associated with the
   Company's efforts to support worldwide marketing & servicing activities. The
   Company believes that as sales increase, the operating expenses as a
   percentage of sales will decrease because of the current capacity of the
   Company's operations.


   Liquidity and Capital Resources

        The Company's highly liquid assets (cash and cash equivalents) at April
   30, 1998 aggregated $484,757, an increase from the $27,946 balance at July
   31, 1997. Its working capital position at April 30, 1998 of $2,457,525
   increased significantly from the comparable amount of $758,111 at July 31,
   1997. The increase in working capital resulted from the Company reducing
   short term liabilities associated with the reorganization proceedings.

        Net cash used in operations for the nine months ended April 30, 1998 was
   $1,998,414, of which $945,328 was used to reduce liabilities subject to the
   Amended Plan of Reorganizaiton and $504,923 was used to purchase inventory.
   Net cash provided by financing activities for the nine months ended April 30,
   1998 was $2,497,378 which included the $2,500,000 private placement the
   Company consummated in August of 1997.

        The Company believes its current cash needs will be adequately provided
   from anticipated cash generated from operations and short-term borrowings.
   Long-term cash requirements, other than normal operating expenses, are
   anticipated for development and enhancement of CYP technology, financing
   anticipated growth and possible acquisitions of certain businesses
   complementary to the Company's business.


   Year 2000 Compliance
   --------------------

        The Company has addressed the "Year 2000 issues" as it affects the
   Company's internal computer programs and believes that its significant
   internal computer programs and systems are currently Year 2000 compliant.


   Forward-Looking Statements for Purposes of "Safe Harbor" Under the Private
   --------------------------------------------------------------------------
   Securities Reform Act of 1995
   -----------------------------

        The Company has made, and may continue to make, various forward-looking
   statements with respect to its financial position, projected costs, projected
   savings and plans and objectives of management. Such forward-looking
   statements are identified by the use of forward-looking words or phrases such
   as "anticipates," "intends," "expects," "plans," "believes," "estimates," or
   words or phrases of similar import. These forward- looking statements are
   subject to numerous assumptions, risks, and uncertainties, and the statements
   looking 

                                       11
<PAGE>

   forward beyond Fiscal 1998 are subject to greater uncertainty because of
   the increased likelihood of changes in underlying factors and assumptions.
   Actual results could differ materially from those anticipated by the
   forward-looking statements.

        The applicable risks and uncertainties include general economic and
   industry conditions that affect all international businesses, as well as
   matters that are specific to the Company and the market it serves. Actual
   sales in Fiscal 1998 may be materially less than the sales projected in the
   forward-looking statements if the Company's customers cancel or delay current
   orders or reduce the rate at which the Company is building or expects to
   build CYP machines for such customers. Such cancellations, delays, or
   reductions may occur if there is a substantial change in the general economy
   or if a customer were to experience major financial difficulties. Margins may
   differ from those projected in the forward-looking statements if management
   does not achieve success in improving margins or other events occur that
   differ from the estimates used in preparing the Company's financial
   statements.

        In addition, all subsequent written and oral forward-looking statements
   attributable to the Company, or persons acting on behalf of the Company, are
   expressly qualified in their entirety by reference to such factors.

        The Company's forward-looking statements represent its judgement only on
   the dates such statements are made. By making any forward-looking statements,
   the Company assumes no duty to update them to reflect new, changed, or
   unanticipated events or circumstances.


   PART II. OTHER INFORMATION

   No reports on Form 8-K were filed by Registrant during the quarterly period
   ended April 30, 1998.


   SIGNATURES


   Pursuant to the requirements of the Securities Exchange Act of 1934, the
   Registrant has duly caused this report to be signed on its behalf by the
   undersigned thereunto duly authorized,



                                     Tapistron International, Inc.
                                     ------------------------------
                                     (Registrant)



   Date:    6/10/98                  /s/ J. Darwin Poe
                                     -----------------------------------------
                                     J. Darwin Poe
                                     (Signing on behalf of the registrant
                                     as President and Chief Executive Officer)


  

                                     12

<TABLE> <S> <C>


   <ARTICLE>                           5
   <LEGEND>
             THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
             THE FINANCIAL STATEMENTS OF TAPISTRON INTERNATIONAL, INC., FOR THE
             THREE MONTHS PERIOD ENDED APRIL 30, 1998, AND IS QUALIFIED IN ITS
             ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
   </LEGEND>
   <MULTIPLIER>                                           1,000
          
   <S>                                 <C>
   <PERIOD-TYPE>                       3-MOS
   <FISCAL-YEAR-END>                                      JUL-31-1998
   <PERIOD-START>                                         FEB-01-1998
   <PERIOD-END>                                           APR-30-1998
   <CASH>                                                 485
   <SECURITIES>                                           0
   <RECEIVABLES>                                          481
   <ALLOWANCES>                                           40
   <INVENTORY>                                            1,670
   <CURRENT-ASSETS>                                       2,832
   <PP&E>                                                 1,360
   <DEPRECIATION>                                         839
   <TOTAL-ASSETS>                                         5,531
   <CURRENT-LIABILITIES>                                  374
   <BONDS>                                                0
                                     0
                                               0
   <COMMON>                                               14
   <OTHER-SE>                                             4,345
   <TOTAL-LIABILITY-AND-EQUITY>                           5,531
   <SALES>                                                955
   <TOTAL-REVENUES>                                       955
   <CGS>                                                  577
   <TOTAL-COSTS>                                          577
   <OTHER-EXPENSES>                                       594
   <LOSS-PROVISION>                                       0
   <INTEREST-EXPENSE>                                     (2)
   <INCOME-PRETAX>                                        (216)
   <INCOME-TAX>                                           0
   <INCOME-CONTINUING>                                    (216)
   <DISCONTINUED>                                         0
   <EXTRAORDINARY>                                        0
   <CHANGES>                                              0
   <NET-INCOME>                                           (216)
   <EPS-PRIMARY>                                          .006
   <EPS-DILUTED>                                          .006
           

   
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission